BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $971,179 | -3.0% | 19,339 | +22.1% | 0.00% | – |
| Q2 2023 | $1,001,246 | +63.0% | 15,843 | +16.1% | 0.00% | – |
| Q1 2023 | $614,091 | +6.5% | 13,650 | +3.7% | 0.00% | – |
| Q4 2022 | $576,583 | -39.2% | 13,161 | -8.6% | 0.00% | -100.0% |
| Q3 2022 | $948,000 | +35.2% | 14,393 | +3.8% | 0.00% | – |
| Q2 2022 | $701,000 | -12.8% | 13,872 | +10.2% | 0.00% | – |
| Q1 2022 | $804,000 | -46.3% | 12,592 | -10.0% | 0.00% | -100.0% |
| Q4 2021 | $1,498,000 | -15.2% | 13,985 | -18.6% | 0.00% | 0.0% |
| Q3 2021 | $1,767,000 | +21.7% | 17,185 | +4.1% | 0.00% | 0.0% |
| Q2 2021 | $1,452,000 | +3.1% | 16,507 | +14.0% | 0.00% | 0.0% |
| Q1 2021 | $1,408,000 | +4.5% | 14,485 | +20.5% | 0.00% | 0.0% |
| Q4 2020 | $1,348,000 | +35.6% | 12,024 | +12.1% | 0.00% | 0.0% |
| Q3 2020 | $994,000 | -16.8% | 10,725 | -29.9% | 0.00% | 0.0% |
| Q2 2020 | $1,194,000 | – | 15,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |